Doctor profile · Federal record
Dr. Inderjit Mehmi, M.D.
Hematology & Oncology Physician (CMS: Medical Oncology) · Internal Medicine Physician · Los Angeles, CA
- NPI 1801092705
- Accepts Medicare
- MIPS 84.1 / 100 · 2023
- 19 yrs in practice
- Licensed in 2 states
- Male
- Group practice
- No sanctions
Practice & contact
Operates at 2 locations .
- Primary practice
-
11800 Wilshire Blvd Fl 3
Los Angeles, CA 900256602
(310) 231-2121
fax (310) 582-7996 - Additional location
-
1 Medical Center Drive
Morgantown, WV 26506
(304) 293-4229
fax (304) 285-7126 - Mailing address
-
Medical Center Dr
Morgantown, WV 26506
Credentials & registration
- NPI registered
- June 2007 — 19 yrs on file
- Profile last updated
- February 5, 2020
- Year of graduation
- 2007 — 19 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State licenses (2)
- West Virginia #24937 · Indiana #01070849A
- Medicaid
- WV #3810024009
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1801092705. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
55,492
Distinct HCPCS
10
Medicare allowed
$2,852,515
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J9271 |
Injection, pembrolizumab, 1 mg | 30,408 | 25 | $54 | |
J9299 |
Injection, nivolumab, 1 mg | 9,500 | 12 | $30 | |
J9228 |
Injection, ipilimumab, 1 mg | 3,903 | 11 | $164 | |
J0897 |
Injection, denosumab, 1 mg | 1,920 | 11 | $23 | |
85025 |
Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 1,313 | 536 | $8 | |
80053 |
Blood test, comprehensive group of blood chemicals | 1,207 | 509 | $10 | |
36415 |
Insertion of needle into vein for collection of blood sample | 874 | 560 | $8 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 717 | 236 | $141 | |
84100 |
Phosphate level | 551 | 227 | $5 | |
84550 |
Uric acid level, blood | 525 | 200 | $4 |
In context: peer comparison
Among 50 peers in Los Angeles Hematology & Oncology Physician, average services per provider: 1,244. This provider delivers 45× the peer median.Open Payments
Industry payments received
All-time total
$23,158
Transactions
36
Manufacturers
6
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 12 | $14,169.43 | |
| Immunocore Limited | 15 | $6,515.68 | |
| Merck Sharp & Dohme LLC | 2 | $2,230.00 | |
| TriSalus Life Sciences, INC. | 1 | $130.07 | |
| Emd Serono, INC. | 4 | $78.57 | |
| Array Biopharma INC | 2 | $33.77 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
278
Patients
14
Total drug cost
$1,397,063
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Letrozole | Generic | 59 | 14 | $3,747 |
| Prednisone | Generic | 25 | 0 | $282 |
| Anastrozole | Generic | 21 | 0 | $797 |
| Mektovi (Binimetinib) | Brand | 21 | 0 | $272,565 |
| Braftovi (Encorafenib) | Brand | 19 | 0 | $309,767 |
| Tafinlar (Dabrafenib Mesylate) | Brand | 19 | 0 | $255,882 |
| Mekinist (Trametinib Dimethyl Sulfoxide) | Brand | 18 | 0 | $281,492 |
| Levothyroxine Sodium | Generic | 16 | 0 | $323 |
| Ondansetron Hcl | Generic | 16 | 0 | $99 |
| Ondansetron Odt (Ondansetron) | Brand | 15 | 0 | $133 |
Hospital affiliations
Frequently asked questions
What is Dr. Inderjit Mehmi's medical specialty?
Dr. Inderjit Mehmi practices Hematology & Oncology Physician in Los Angeles, CA.
Where does Dr. Inderjit Mehmi practice?
Dr. Inderjit Mehmi practices at 11800 Wilshire Blvd Fl 3, Los Angeles, CA 900256602. Office phone: 3102312121.
What is Dr. Inderjit Mehmi's NPI?
Dr. Inderjit Mehmi's National Provider Identifier (NPI) is 1801092705, issued by NPPES.
Does Dr. Inderjit Mehmi accept Medicare assignment?
Yes. Dr. Inderjit Mehmi accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Inderjit Mehmi commonly perform?
Top Medicare-reported procedures in 2023: Injection, pembrolizumab, 1 mg (HCPCS J9271); Injection, nivolumab, 1 mg (HCPCS J9299); Injection, ipilimumab, 1 mg (HCPCS J9228). Source: CMS Medicare Physician & Other Practitioners file.